Willow vs Zealthy: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Willow beats Zealthy overall, scoring 8.2/10 vs 7.2/10. Zealthy is more affordable at $286/mo vs $299/mo. Choose Willow for users who want comprehensive clinical support with flexibili. Choose Zealthy for users who want the option to switch between compounded and b.
A side-by-side comparison of Willow and Zealthy covering pricing, scores, medication types, insurance, and more to help you decide.
Willow
#8 of 48Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.
Visit WillowZealthy
#42 of 48Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.
Visit Zealthy| Feature | Willow | Zealthy |
|---|---|---|
| Our Score | 8.2/10 | 7.2/10 |
| Starting Price | $299/mo | $286/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes | Users who want the option to switch between compounded and brand-name GLP-1s |
| Ranking | #8 | #42 |
Pros & Cons Compared
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
- +$299/mo all-in for compounded semaglutide with monthly provider support
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Compounded-only — no brand-name Wegovy or Zepbound through the platform
- −Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Zealthy
Pros
- +Dedicated insurance coordinators handle prior authorizations — potentially bringing brand-name GLP-1 costs to $25/mo
- +Multi-month supply options (3, 6, or 12 months) — unique convenience most monthly-shipping competitors can't match
- +Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
- +LegitScript certified with 4.5-star Review.io rating
Cons
- −$135 membership fee on top of medication cost makes cash-pay total ~$286/mo for semaglutide — above average
- −Young company (founded 2023) with a relatively small review base — less track record than established platforms
- −Prescription products are non-refundable for any reason once ordered
Our Verdict
Willow edges out Zealthy with a score of 8.2/10 vs 7.2/10. If budget is your priority, Zealthy starts at $286/mo compared to Willow's $299/mo. Zealthy offers both brand-name and compounded medications, giving you more flexibility. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes. Choose Zealthy if you want: users who want the option to switch between compounded and brand-name glp-1s.
Still undecided? Editor's #1 Overall Pick
Eden Health GLP-1
$249/mo · 8.9/10 · Both
If neither Willow nor Zealthy feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Willow or Zealthy tend to look at next.
- Willow vs MyStart Health$299/mo
- Willow vs Direct Meds GLP-1$297/mo
- Willow vs DudeMeds$149/mo
- Zealthy vs Eden Health GLP-1$249/mo
- Zealthy vs Found$264/mo
- Zealthy vs Sprout Health$249/mo